FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: Massachusetts is a significant hub for biotechnology, and the potential approval of Moderna's mRNA flu vaccine could have a substantial impact on the state's life sciences industry, including research, development, and manufacturing sectors. This decision could influence investment and job growth within the state's robust biotech ecosystem.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.